Advance Notice: VIP 9 Spot Trading Fee Adjustment

Publicado el 10 ago 2026lectura de 2 min
Puede que esta información no sea aplicable a todos los clientes
Inicia sesión para comprobar si los productos, las funciones, las normas y los términos de este artículo son aplicables a ti.

Dear OKX users,

OKX will adjust the Spot Group 1 trading fees for VIP 9 users on Aug 14, 2026, 15:00–17:00 (UTC+8). The changes are as follows:

User tier

Fee type

Current rate

New rate

VIP 9

Spot Maker fee

-0.0075%

-0.0050%

VIP 9

Spot Taker fee

0.0175%

0.0150%


This adjustment applies only to Spot Group 1. Fees for other VIP tiers and other spot trading pair groups will remain unchanged.

Questions?

We encourage customers to review these changes and adjust trading strategies as needed. For more details, please contact Customer Support.

Institutional and VIP Clients

For assistance, please contact your Relationship Manager via your existing private OKX Telegram group, the @OKX_Institutions Telegram group, or email institutional@okx.com.


Thank you for your continued support.


OKX Australia Team

Disclaimer: Information about: digital currency exchange services is prepared by OKX Australia Pty Ltd (ABN 22 636 269 040); derivatives and margin by OKX Australia Financial Pty Ltd (ABN 14 145 724 509, AFSL 379035); and other products and services by the relevant OKX entities which offer them (see Terms of Service). This information is general in nature and does not take into account your objectives, financial situation or needs. You should do your own research and obtain professional advice, including to ensure you understand the risks associated with these products, before you make a decision about them. Digital assets are volatile and carry a high level of risk; you may lose some or all of your investment. Crypto derivatives carry significant risk. You could lose all of the USDT deposited in your trading account. Past performance is not indicative of future performance. Read our Terms of Service and Risk Disclosure Statement for more information.